S
Shweta Sharma
Researcher at University of Puerto Rico, Río Piedras
Publications - 4
Citations - 151
Shweta Sharma is an academic researcher from University of Puerto Rico, Río Piedras. The author has contributed to research in topics: Apoptosis & Conjugate. The author has an hindex of 4, co-authored 4 publications receiving 102 citations.
Papers
More filters
Journal ArticleDOI
Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and Toxicity.
Arthur D. Tinoco,Manoj Saxena,Shweta Sharma,Nicholas Noinaj,Yamixa Delgado,Ernesto P. Quiñones González,Steven E. Conklin,Nicole Zambrana,Sergio A. Loza-Rosas,Timothy B. Parks +9 more
TL;DR: The first X-ray crystal structure of a Ti(IV)-bound sTf is solved, which provides the first glimpse into the citrate-transferrin synergism in the regulation of Ti( IV) bioactivity and offers insight into the future design of Ti-based anticancer drugs.
Journal ArticleDOI
Fueling a Hot Debate on the Application of TiO2 Nanoparticles in Sunscreen.
Shweta Sharma,Rohit Kumar Sharma,Kavita Gaur,José F. Cátala Torres,Sergio A. Loza-Rosas,Anamaris Torres,Manoj Saxena,Mara Julin,Arthur D. Tinoco +8 more
TL;DR: By closely examining the biological use of TiO2 and the influence of biomolecules on its stability and solubility, the reactivity of the material is reassessed in the presence and absence of UV energy.
Journal ArticleDOI
Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body
Manoj Saxena,Sergio A. Loza-Rosas,Kavita Gaur,Shweta Sharma,Sofia C. Pérez Otero,Arthur D. Tinoco +5 more
TL;DR: Based on its chemical similarities with Fe, the biological coordination chemistry of Fe(III) and Ti(IV) is compared and it is hypothesized that Ti( IV) can bind to similar intracellular biomolecules and inhibit Fe bioavailability.
Journal ArticleDOI
Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate.
Manoj Saxena,Yamixa Delgado,Rohit Kumar Sharma,Shweta Sharma,Solimar Liz Ponce De León Guzmán,Arthur D. Tinoco,Kai Griebenow +6 more
TL;DR: The neo-conjugate developed has promise for future development to target cancers with enhanced transferrin receptor expression and maintained an IC50 value similar to the well known drug cisplatin in A549 cancer cells but also was nontoxic to the normal lung (MRC5) cells.